Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002899147 | SCV003243669 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2022-06-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has not been reported in the literature in individuals affected with SUN2-related conditions. This variant is present in population databases (rs182710324, gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 614 of the SUN2 protein (p.Arg614Cys). |
Ambry Genetics | RCV004867814 | SCV005511369 | uncertain significance | not specified | 2024-12-04 | criteria provided, single submitter | clinical testing | The c.1840C>T (p.R614C) alteration is located in exon 16 (coding exon 15) of the SUN2 gene. This alteration results from a C to T substitution at nucleotide position 1840, causing the arginine (R) at amino acid position 614 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |